Sign Up to like & get
recommendations!
2
Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.937958
Abstract: Introduction Phosphodiesterase type 5-inhibitors (PDE5is) are the first-line treatment for patients with diabetes mellitus-induced erectile dysfunction (DMED), however, some patients are non-responser to PDE5is. We performed a perspective, randomized, comparative study to explore the efficacy…
read more here.
Keywords:
weeks weeks;
efficacy;
group;
eswt combined ... See more keywords